Natera (NTRA) Total Non-Current Liabilities (2014 - 2026)
Natera's (NTRA) quarterly Total Non-Current Liabilities came in at $737.2 million in Q1 2026, up 9.33% on a QoQ basis from $674.2 million in Q4 2025.
Natera (NTRA) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Natera (NTRA) has 10 years of Total Non-Current Liabilities data on file, last reported at $737.2 million in Q1 2026.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $737.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $737.2 million (changed N/A YoY) and the FY2025 annual result came in at $674.2 million, up 47.39% from the prior year.
- Total Non-Current Liabilities grew to $737.2 million in Q1 2026, from $674.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $737.2 million in Q1 2026 to a low of $457.5 million in Q4 2024.
- A 4-year average of $617.5 million and a median of $618.8 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 320.65% — and 2025, when it soared 47.39%.
- Tracing NTRA's Total Non-Current Liabilities over 4 years: stood at $618.8 million in 2022, then slipped by 26.07% to $457.5 million in 2024, then surged by 47.39% to $674.2 million in 2025, then gained by 9.33% to $737.2 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $737.2 million (Q1 2026), $674.2 million (Q4 2025), and $457.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Labcorp Holdings | 25.86 Bn | 24.87 Bn | 1.01 Bn | 9.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 737.18 Mn |
| Dec 31, 2025 | 674.24 Mn |
| Dec 31, 2024 | 457.47 Mn |
| Jun 30, 2022 | 618.78 Mn |
| Mar 31, 2022 | 599.80 Mn |
| Dec 31, 2021 | 581.70 Mn |
| Sep 30, 2021 | 550.89 Mn |
| Jun 30, 2021 | -320.15 Mn |
| Mar 31, 2021 | -271.83 Mn |
| Dec 31, 2020 | 445.60 Mn |
| Sep 30, 2020 | 440.40 Mn |
| Jun 30, 2020 | 418.68 Mn |
| Mar 31, 2020 | 299.40 Mn |
| Dec 31, 2019 | 303.64 Mn |
| Dec 31, 2017 | 187.87 Mn |
| Sep 30, 2015 | 21.28 Mn |
| Jun 30, 2015 | 25.43 Mn |
| Dec 31, 2014 | 24.47 Mn |